Phase III clinical trial of JTE-350 - Skin Prick Test of JTE-350 in Healthy Volunteers -

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222252

Enrollment

Registered

2013-10-09

Start date

2013-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Positive control of Skin Prick Test for allergy diagnosis

Interventions

investigational material(s) Generic name etc : JTE-350 INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Healthy Volunteers 20 to 65 years of age on the day of informed consent 2) Subjects signed written informed consent

Exclusion criteria

Exclusion criteria: 1) Subjects with a history of serious drug allergy or subjects who have ever experienced systemic allergy due to skin prick test. 2) Subjects with treatmets to affect skin prick test result, for example anti-histamine drug

Design outcomes

Primary

Measure	Time frame
Positive rate of JTE-350 After 15 minutes, the wheal diameter is 3mm or longer	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026